Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy

Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Moshe Talpaz, Susan O'Brien, Francis Giles, Stefan Faderl, William Wierda, Mary Beth Rios, Jianqin Shan, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences